Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Common stock, balance at beginning of period (in shares) at Dec. 31, 2022		219,656,587
Balance at beginning of period at Dec. 31, 2022	$ 672,735	$ 220	$ 672,990	$ 0	$ (475)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	9,099			9,099
Issuance of common stock upon vesting or exercise of stock-based awards, net of withholding tax (in shares)		43,671
Issuance of common stock upon vesting or exercise of stock-based awards, net of withholding tax	(169)		(169)
Forfeiture of unvested common stock and dividend equivalents			275
Forfeiture of unvested common stock (in shares)		(103,906)
Forfeiture of unvested common stock and dividend equivalents	275
Repurchase of common stock (in shares)		(346,699)
Repurchase of common stock	(3,244)	$ (1)	(3,243)
Dividend equivalents issued	4,366		4,366
Stock-based compensation	10,895		10,895
Other comprehensive income (loss)	206				206
Common stock, balance at end of period (in shares) at Mar. 31, 2023		219,249,653
Balance at end of period at Mar. 31, 2023	694,163	$ 219	685,114	9,099	(269)
Common stock, balance at beginning of period (in shares) at Dec. 31, 2023		217,915,713
Balance at beginning of period at Dec. 31, 2023	534,873	$ 218	505,864	28,514	277
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	19,647			19,647
Issuance of common stock upon vesting or exercise of stock-based awards, net of withholding tax (in shares)		548,344
Issuance of common stock upon vesting or exercise of stock-based awards, net of withholding tax	(2,323)	$ 1	(2,324)
Forfeiture of unvested common stock and dividend equivalents (in shares)		(64,001)
Forfeiture of unvested common stock and dividend equivalents	73		73
Repurchase of common stock (in shares)		(1,697,272)
Repurchase of common stock	(10,795)	$ (2)	(10,793)
Stock-based compensation	11,473		11,473
Other comprehensive income (loss)	(376)				(376)
Common stock, balance at end of period (in shares) at Mar. 31, 2024		216,702,784
Balance at end of period at Mar. 31, 2024	$ 552,572	$ 217	$ 504,293	$ 48,161	$ (99)